Related references
Note: Only part of the references are listed.Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4]thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase
Mark J. Karbarz et al.
ANESTHESIA AND ANALGESIA (2009)
Genetic Loss of Faah Compromises Male Fertility in Mice
Xiaofei Sun et al.
BIOLOGY OF REPRODUCTION (2009)
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Kay Ahn et al.
CHEMISTRY & BIOLOGY (2009)
Synthesis and Evaluation of Benzothiazole-Based Analogues as Novel, Potent, and Selective Fatty Acid Amide Hydrolase Inhibitors
Xueqing Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception
Pattipati S. Naidu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Endocannabinoid Modulation of Scratching Response in an Acute Allergenic Model: A New Prospective Neural Therapeutic Target for Pruritus
Joel E. Schlosburg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Jonathan Z. Long et al.
NATURE CHEMICAL BIOLOGY (2009)
Fatty Acid Amide Hydrolase Inhibition Heightens Anandamide Signaling Without Producing Reinforcing Effects in Primates
Zuzana Justinova et al.
BIOLOGICAL PSYCHIATRY (2008)
Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH)
Amy Timmons et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase
John M. Keith et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling
Heather S. Hoover et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Identification of productive inhibitor binding orientation in fatty acid amide hydrolase (FAAH) by QM/MM mechanistic modelling
Alessio Lodola et al.
CHEMICAL COMMUNICATIONS (2008)
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Kay Ahn et al.
CHEMICAL REVIEWS (2008)
Biosynthesis, degradation and pharmacological importance of the fatty acid amides
Emma K. Farrell et al.
DRUG DISCOVERY TODAY (2008)
Activation of cannabinoid CB, receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test
Sabrina F. Lisboa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Cannabinoid and opioid modulation of social play behavior in adolescent rats: Differential behavioral mechanisms
Viviana Trezza et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets
Francis Rodriguez Bambico et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Discovery of Boronic Acids as Novel and Potent Inhibitors of Fatty Acid Amide Hydrolase
Anna Minkkila et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Optimization of the central heterocycle of α-ketoheterocycle inhibitors of fatty acid amide hydrolase
Joie Garfunkle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Optimization of α-ketooxazole inhibitors of fatty acid amide hydrolase
F. Scott Kimball et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: Modulation at the N-portion of biphenyl-3-yl alkylcarbamates
Marco Mor et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors
Mark Seierstad et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Targeting endocannabinoid degradation protects against experimental colitis in mice:: involvement of CB1 and CB2 receptors
Martin A. Storr et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Endogenous Fatty Acid Ethanolamides Suppress Nicotine-Induced Activation of Mesolimbic Dopamine Neurons through Nuclear Receptors
Miriam Melis et al.
JOURNAL OF NEUROSCIENCE (2008)
Inhibition of Anandamide Hydrolysis by Cyclohexyl Carbamic Acid 3′-Carbamoyl-3-yl Ester (URB597) Reverses Abuse-Related Behavioral and Neurochemical Effects of Nicotine in Rats
Maria Scherma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Targeting the endocannabinoid system: to enhance or reduce?
Vincenzo Di Marzo
NATURE REVIEWS DRUG DISCOVERY (2008)
The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome
M. A. Storr et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Evaluation of fatty acid amides in the carrageenan-induced paw edema model
Laura E. Wise et al.
NEUROPHARMACOLOGY (2008)
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition
Maria Scherma et al.
NEUROPHARMACOLOGY (2008)
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
Fabricio A. Moreira et al.
NEUROPHARMACOLOGY (2008)
Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse
J. A. Palmer et al.
NEUROSCIENCE (2008)
Structure-guided inhibitor design for human FAAH by interspecies active site conversion
Mauro Mileni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters
Anna M. Moise et al.
PSYCHOPHARMACOLOGY (2008)
Bidirectional cannabinoid modulation of social behavior in adolescent rats
Viviana Trezza et al.
PSYCHOPHARMACOLOGY (2008)
The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat
Erin M. Rock et al.
PSYCHOPHARMACOLOGY (2008)
Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress
Marco Bortolato et al.
BIOLOGICAL PSYCHIATRY (2007)
Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity
Kyunghye Ahn et al.
BIOCHEMISTRY (2007)
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats
Sandor Batkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Structure-activity relationships of α-ketooxazole inhibitors of fatty acid amide hydrolase
Christophe Hardouin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: Studies of drug use and dependence in Caucasians
Rachel F. Tyndale et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Role of endocannabinoids in alcohol consumption and intoxication: Studies of mice lacking fatty acid amide hydrolase
Yuri A. Blednov et al.
NEUROPSYCHOPHARMACOLOGY (2007)
The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice
Roberto Russo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats
Carlo Nucci et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Endocannabinoids and related compounds: Walking back and forth between plant natural products and animal physiology
Vincenzo Di Marzo et al.
CHEMISTRY & BIOLOGY (2007)
Novel inhibitors of fatty acid amide hydrolase
S. Y. Sit et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality
Pattipati S. Naidu et al.
PSYCHOPHARMACOLOGY (2007)
The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites
Dorit P. Jensen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Development of highly sensitive fluorescent assays for fatty acid amide hydrolase
Huazhang Huang et al.
ANALYTICAL BIOCHEMISTRY (2007)
A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase
Karen L. Kage et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Potent and selective α-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase
F. Anthony Romero et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets
Di Zhang et al.
NEUROPHARMACOLOGY (2007)
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
Anatol C. Kreitzer et al.
NATURE (2007)
Critical enzymes involved in endocannabinoid metabolism
Balapal S. Basavarajappa
PROTEIN AND PEPTIDE LETTERS (2007)
Biosynthetic pathways of the endocannabinoid anandamide
Yasuo Okamoto et al.
CHEMISTRY & BIODIVERSITY (2007)
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
Leon Chang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain
Maulik D. Jhaveri et al.
JOURNAL OF NEUROSCIENCE (2006)
A second fatty acid amide hydrolase with variable distribution among placental mammals
Binqing Q. Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The cannabinoid system and its pharmacological manipulation - a review, with emphasis upon the uptake and hydrolysis of anandamide
Christopher J. Fowler
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)
Delineation of a fundamental α-ketoheterocycle substituent effect for use in the design of enzyme inhibitors
F. Anthony Romero et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice
Victoria L. Haller et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases
Jessica P. Alexander et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Fatty acid amide hydrolase deficiency limits early pregnancy events
Haibin Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling
Sachin Patel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)
Daniele Piomelli et al.
CNS DRUG REVIEWS (2006)
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
A Jayamanne et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of a high-affinity binding site involved in the transport of endocannabinoids
SA Moore et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mechanism of carbamate inactivation of FAAH: Implications for the design of covalent inhibitors and in vivo functional probes for enzymes
JP Alexander et al.
CHEMISTRY & BIOLOGY (2005)
Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors
S Holt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Anandamide transport: A critical review
ST Glaser et al.
LIFE SCIENCES (2005)
The endocannabinoid system: Drug targets, lead compounds, and potential therapeutic applications
DM Lambert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
JC Sipe et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
An endocannabinoid mechanism for stress-induced analgesia
AG Hohmann et al.
NATURE (2005)
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597):: Effects on anandamide and oleoylethanolamide deactivation
D Fegley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Discovery of a potent, selective, and efficacious class of reversible α-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics
DL Boger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity
D Leung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Structure and function of fatty acid amide hydrolase
MK McKinney et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2005)
The endogenous cannabinoid system protects against colonic inflammation
F Massa et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The development and application of methods for activity-based protein profiling
N Jessani et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Chemical strategies for activity-based proteomics
AE Speers et al.
CHEMBIOCHEM (2004)
Biochemical mechanisms of drug action: what does it take for success?
DC Swinney
NATURE REVIEWS DRUG DISCOVERY (2004)
Functional disassociation of the central and peripheral fatty acid amide signaling systems
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala
AI Gulyas et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: Evidence for an unprecedented combination of potency and selectivity
AH Lichtman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia
AH Lichtman et al.
PAIN (2004)
Recent advances in the medicinal chemistry of α-aminoboronic acids, amine-carboxyboranes and their derivatives
VM Dembitsky et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2004)
Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors:: Synthesis, quantitative structure-activity relationships, and molecular modeling studies
M Mor et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
S Bátkai et al.
CIRCULATION (2004)
Evidence for distinct roles in catalysis for residues of the serine-serine-lysine catalytic triad of fatty acid amide hydrolase
MK McKinney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system
BF Cravatt et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors
G Tarzia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Discovering potent and selective reversible inhibitors of enzymes in complex proteomes
D Leung et al.
NATURE BIOTECHNOLOGY (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
Modulation of anxiety through blockade of anandamide hydrolysis
S Kathuria et al.
NATURE MEDICINE (2003)
Cellular accumulation of anandamide: consensus and controversy
CJ Hillard et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation
TP Dinh et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2002)
Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling
MH Bracey et al.
SCIENCE (2002)
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
JC Sipe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer
M Maccarrone et al.
MOLECULAR HUMAN REPRODUCTION (2002)
The palmitoylethanolamide family: A new class of anti-inflammatory agents?
DM Lambert et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
BF Cravatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Profiling serine hydrolase activities in complex proteomes
D Kidd et al.
BIOCHEMISTRY (2001)
Clarifying the catalytic roles of conserved residues in the amidase signature family
MP Patricelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage
M Maccarrone et al.
LANCET (2000)
Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
DL Boger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)